GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prostatype Genomics AB (OSTO:PROGEN) » Definitions » Pretax Margin %

Prostatype Genomics AB (OSTO:PROGEN) Pretax Margin % : -18,008.93% (As of Jun. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Prostatype Genomics AB Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Prostatype Genomics AB's Pre-Tax Income for the three months ended in Jun. 2023 was kr-10.09 Mil. Prostatype Genomics AB's Revenue for the three months ended in Jun. 2023 was kr0.06 Mil. Therefore, Prostatype Genomics AB's pretax margin for the quarter that ended in Jun. 2023 was -18,008.93%.

The historical rank and industry rank for Prostatype Genomics AB's Pretax Margin % or its related term are showing as below:

OSTO:PROGEN' s Pretax Margin % Range Over the Past 10 Years
Min: -156300   Med: -5751.85   Max: -3055.68
Current: -3944.26


OSTO:PROGEN's Pretax Margin % is ranked worse than
97.25% of 218 companies
in the Medical Diagnostics & Research industry
Industry Median: -12.805 vs OSTO:PROGEN: -3944.26

Prostatype Genomics AB Pretax Margin % Historical Data

The historical data trend for Prostatype Genomics AB's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prostatype Genomics AB Pretax Margin % Chart

Prostatype Genomics AB Annual Data
Trend Jun18 Jun19 Dec21 Dec22 Dec23
Pretax Margin %
-5,751.85 -11,548.65 -156,300.00 -4,258.71 -3,055.68

Prostatype Genomics AB Quarterly Data
Jun18 Jun19 Mar20 Jun20 Sep20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7,258.18 -2,675.41 -1,992.35 -18,008.93 -

Competitive Comparison of Prostatype Genomics AB's Pretax Margin %

For the Diagnostics & Research subindustry, Prostatype Genomics AB's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prostatype Genomics AB's Pretax Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Prostatype Genomics AB's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Prostatype Genomics AB's Pretax Margin % falls into.



Prostatype Genomics AB Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Prostatype Genomics AB's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-41.435/1.356
=-3,055.68 %

Prostatype Genomics AB's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=-10.085/0.056
=-18,008.93 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Prostatype Genomics AB  (OSTO:PROGEN) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Prostatype Genomics AB Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Prostatype Genomics AB's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Prostatype Genomics AB (OSTO:PROGEN) Business Description

Traded in Other Exchanges
Address
Gustaf III:s Boulevard 34, Solna, SWE, 169 73
Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. By assessing the aggressiveness of prostate cancer, Prostatype helps clinicians and patients to make correct treatment decisions. Over and under treatment of prostate cancer can be minimized, the quality of life for the patient improved and money can be saved for the health care sector.

Prostatype Genomics AB (OSTO:PROGEN) Headlines

No Headlines